Skip to Main Content

Paper Details

The Cancer Genome Atlas Expression Subtypes Stratify Response to Checkpoint Inhibition in Advanced Urothelial Cancer and Identify a Subset of Patients with High Survival Probability.
Eur Urol
111
2019
Advanced Urothelial Cancer, Cancer, Cancer Genome Atlas, PATIENT, PD-L1, Patients, TGF, bladder cancer tumor, cisplatin, neuronal subtype, patient, patients, platinum, platinum-refractory or cisplatin-ineligible urothelial carcinoma, tumor, tumor samples
Author NameAffiliation
Jaegil KimThe Broad Institute of MIT and Harvard
David J McConkeyGreenberg Bladder Cancer Institute, Johns Hopkins University
Samuel S FreemanThe Broad Institute of MIT and Harvard
Samuel S FreemanThe Broad Institute of MIT and Harvard
Gad GetzThe Broad Institute of MIT and Harvard
Gad GetzThe Broad Institute of MIT and Harvard
  • 1 - 6

Datasets

Release 1.2